THE introduction of corticosteroid drugs in I949, thanks to the pioneer work of Kendall, Reichstein and Winterstein, ranks as one of the greatest medical advances of all time and probably the greatest since antibiotics were discovered a couple of decades ago. In no other field, probably, has their application been of greater service than in dermhatology, and they have now been employed long enough for a reassessment of their worth.
Under the influence of the pituitary adrenocorticotrophic hormone, which is probably under hypothalamic control, a variety of steroids is secreted by the adrenal gland including hydrocortisone (or cortisol), corticosterone, aldosterone and sex hormones like progesterone, estrogens and androgens. There is a reciprocal relationship between the concentration of circulating corticotrophin and of adrenal cortical hormones. Hydrocortisone, which like corticosterone and cortisone belongs to the i i-oxysteroid group of adrenal corticosteroidsso called because an=O or -OH group is attached to C in the i i position-is secreted by the human adrenal cortex in far greater amounts than any of the other hormones. Cortisone, the first of the synthetic corticosteroids to be manufactured, is not produced by the adrenal gland, and when administered therapeutically is probably converted into hydrocortisone which is the active hormone. In recent years several hundred analogues of cortisone have been prepared by inserting additional groups into the parent structure in an attempt to eliminate undesirable mineralocorticoid sodium retaining and potassium losing effects by virtue of the lower dosage required, but the perfect analogue has yet to be discovered. The introduction of double bonds between i and 2 carbon atoms in ring A produced the more potent prednisone and prednisolone. The attachment of a fluorine atom to the 9C position yielding fludrocortisone further enhanced the anti-inflammatory effect while adding a hydroxyl or a methyl group to the latter reduced sodium retention and produced triamcinolone and dexamethasone respectively. More recent additions are betamethasone and paramethasone. Pharmacological Effects A thorough understanding of the metabolic effects of these agents is essential for their proper clinical use and for the minimization of undesirable side reactions. The corticosteroids employed therapeutically are generally called glucocorticoids because of their easily observed effects on carbohydrate metabolism. They raise the blood sugar level by decreasing the utilization of glucose, by converting amino acids into glucose (gluconeogenesis) and possibly also by hindering the tubular reabsorption of glucose. Thus their effect is diabetogenic and when they are present in excess, hyperglyclemia, glycosuria and impared glucose tolerance may result.
Their effect on protein metabolism may be catabolic or anti-anabolic with interference with protein synthesis. A negative nitrogen balance results with accompanying retardation or cessation of growth, muscle wasting, thinning of the skin, defective tissue repair, strife, spontaneous bruising and osteoporosis.
Lipid metabolism is affected, there being a redistribution of body fat with an accumulation on the face ('moon face') and a deposition on the nape of the neck ('buffalo hump') and the abdomen at the expense of fat in the extremities as in Cushing's syndrome.
The mineralocorticoid fraction influences electrolyte and water metabolism promoting the retention of sodium and the excretion of potassium. CEdema, hypertension and beart failure may ensue.
A negative calcium balance from increased fiecal excretion and an abnormal phosphate loss may lead to osteoporosis and vertebral collapse. There is some evidence suggesting that adrenal corticosteroids are antagonistic to Vitamin D. The blood components are influenced, the number of circulating eosinophils and lymphocytes being reduced, while polycythmmia may occur.
Mode of Action and Therapeutic Effects
To many patients the corticosteroid must indeed seem the wonder drug of this age, but nature exacts a high price for the apparent miracle and corticosteroids are a double-edged weapon with a power for evil as well as for good.
The corticosteroids are apparently simple substances chemically and though their action at the molecular or even cellular level remains unexplained, they are thought possibly to be co-factors essential to enzymic reactions, the catalytic action being probably at a physical rather than a chemical level. The pharmacological use of these drugs implies the employment of unphysiological doses and depends on the production of a state of hypercorticalism. Cutaneous effects of corticosteroid therapy include also follicular hyperkeratinization, decreased formation of sebum and increased sweating. As already stated the skin participates in the depletion of body protein, becoming atrophic and fragile and strix may occur from thinning of collagenous and elastic fibres. Purpura may occur from collagen degeneration as in senile purpura. Dorfman and Schiller (1958) When the patient has become sensitive to a vitally needed drug its continued administration may, on occasion, be rendered possible, or desensitization attempted, by concomitant steroid therapy, though these procedures are not without risk.
Acute Radiodermatitis. In a recent series (Sweet I962) of accidentally produced superficial X-ray burns, it was felt that though treatment with large doses of oral prednisolone had no effect in preventing epidermal loss with epilation, it postponed the subsequent necrosis of the dermal and deeper tissues (probably by inhibiting the vascular occlusion resulting from fibrosis of the walls of blood vessels) and appeared to lessen pain and help the maintenance of function.
Atopic eczema calls for special comment. In a very chronic disorder of this nature the patients have, of necessity, learned to live with their disability and this they are prepared to do. When, however, the magic drug capable of causing relief in almost miraculous fashion is exhibited and then subsequently withdrawn, they frequently become intensely depressed, intolerant of the slightest recrudescence and unable to adjust themselves to the new state of affairs. I have found it exceedingly difficult to wean some of these patients from their steroids once effective relief has been obtained and to this extent the drug may be regarded as one of addiction. To borrow a phrase-'We have got a tiger by the tail and we dare not let go'-for on every occasion on which an effort is made to diminish the dosage the patient's skin flares up violently. Nevertheless, some cases of atopic eczema are so severe and disabling and interfere with all the patients activities to such an extent that systemic corticosteroid therapy may become permissible, but one must be prepared to continue minimal suppressive therapy for months or even years if necessary.
Systemic corticosteroids are not advised in infantile eczema nor in psoriasis (except the erythrodermic type) nor in alopecia areata. Local Corticosteroid Therapy
Corticosteroid preparations for topical therapy are now in very wide use and the multiplicity of available preparations equals that of the systemically used drugs and is bewildering. (Pillsbury and Shelley, I963) . Unfortunately, the effects tend to be temporary and dermal atrophy, and occasionally ulceration, may occur. Some systemic effect may be exerted and therefore due care must be taken in the selection of cases.
Corticotrophin
Pituitary corticotrophin, a polypeptide consisting of 39 amino-acids linked together, can only be administered by injection and has now largely been replaced by the orally effective corticosteroids which possess obvious advantages.
The therapeutic and side effects are very largely the same, but it produces a clinical response in a shorter time than an equivalent amount of corticosteroid and the effects wear off less rapidly than those of cortisone when the drug is discontinued. Cortisone can be regulated more accurately than corticotrophin, the effects of which are more liable to fluctuation and presuppose a normally responsive adrenal cortex.
For temporary maximal stimulation 6o units of Acthar gel I1 hourly (for not more than 2 days) and for moderate stimulation 40 units can be given. For practical purposes the use of corticotrophin is largely confined to initiating a therapeutic response and to activating the adrenal cortex prior to discontinuing steroid therapy. In the latter case 20-40 units of Acthar gel by intramuscular injection twice weekly for three to four weeks may be given.
In some cases of severe life-threatening dermatoses where a state of apparent refractoriness to even very large doses of corticosteroids appears to have been reached, their partial substitution or supplementation by appropriately spaced injections of corticotrophin sometimes appears to be of value. It is evident that though the introduction of adrenal corticosteroids has brought an addition of the first magnitude to the dermatological armamentarium, it has in no way over-simplified the management of diseases of the skin.
